Related Experiment Videos
beta-cell function and glucose and lipid oxidation in Graves' disease
Clinical Endocrinology
|January 1, 1996
Summary
Thyrotoxicosis impairs glucose tolerance via dual beta-cell defects and altered lipid metabolism. Thyroid hormones increase oxidation, but sympathetic response is blunted in Graves' disease patients.
Area of Science:
- Endocrinology
- Metabolic Research
- Thyroidology
Background:
- Thyrotoxicosis is linked to abnormal glucose metabolism and impaired glucose tolerance.
- The precise pathogenesis of these metabolic disturbances remains incompletely understood.
Purpose of the Study:
- To investigate beta-cell function in patients with thyrotoxicosis.
- To examine meal-induced oxidative glucose and lipid metabolism in thyrotoxicosis.
Main Methods:
- Compared 9 untreated Graves' disease patients with 9 healthy controls.
- Utilized indirect calorimetry to assess glucose and lipid oxidation.
- Calculated insulin secretion rates and correlated them with glucose levels to evaluate beta-cell sensitivity.
Main Results:
- Hyperthyroid patients showed increased fasting and post-prandial glucose levels.
- A 'dual' beta-cell defect was observed: inadequate insulin response to hyperglycemia and elevated proinsulin.
- Increased lipid oxidation and enhanced post-prandial glucose oxidation were noted in patients.
Conclusions:
- Untreated Graves' disease causes glucose intolerance due to quantitative and qualitative beta-cell defects.
- Thyroid hormones enhance oxidation, but this is not mediated by increased catecholamines; sympathetic response is blunted.
- Metabolic alterations in thyrotoxicosis involve both glucose and lipid pathways.